CNTN2 and adult T-cell leukemia/lymphoma: Treatment of ATLL cells with arsenic trioxide and IFN-α triggered the proteasomal degradation of Tax and cell death, suggesting that a therapeutic approach targeting Tax may indeed improve outcomes in ATLL patients69.